FDA
approval
· 2019-02-21
FDA Approved: CIPROFLOXACIN AND DEXAMETHASONE — Supplemental Application (Sandoz Inc)
Summary
FDA approved a supplemental application for ciprofloxacin and dexamethasone from Sandoz, updating the approval status for this otic suspension product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CIPROFLOXACIN AND DEXAMETHASONE (CIPROFLOXACIN AND DEXAMETHASONE)